These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38409569)

  • 21. Alterations of urine microRNA-7977/G6PD level in patients with diabetic kidney disease and its association with dysfunction of albumin-induced autophagy in proximal epithelial tubular cells.
    Shi Z; Li X; Zhang L; Xie J; Zhong F; Guo Z; Gao Z; Wang J; Mahto RK; Li Y; Wang S; Chang B; Stanton RC; Yang J
    Am J Physiol Endocrinol Metab; 2024 Oct; 327(4):E512-E523. PubMed ID: 39140974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways.
    Lei L; Zhao J; Liu XQ; Chen J; Qi XM; Xia LL; Wu YG
    Drug Des Devel Ther; 2021; 15():3131-3150. PubMed ID: 34295152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease.
    Liu J; Ren J; Zhou L; Tan K; Du D; Xu L; Cao W; Zhang Y
    J Ethnopharmacol; 2024 Nov; 334():118517. PubMed ID: 38972525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RUNX3 alleviates mitochondrial dysfunction and tubular damage by inhibiting TLR4/NF-κB signalling pathway in diabetic kidney disease.
    Xiao L; Ye G
    Nephrology (Carlton); 2024 Aug; 29(8):470-481. PubMed ID: 38735649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice.
    Liu W; Chen X; Wang Y; Chen Y; Chen S; Gong W; Chen T; Sun L; Zheng C; Yin B; Li S; Luo C; Huang Q; Xiao J; Xu Z; Peng F; Long H
    Pharmacol Res; 2019 Dec; 150():104506. PubMed ID: 31669149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway.
    Zhou L; Xu DY; Sha WG; Shen L; Lu GY; Yin X; Wang MJ
    J Transl Med; 2015 Nov; 13():352. PubMed ID: 26552447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asiatic acid attenuates tubular injury in diabetic kidney disease by regulating mitochondrial dynamics via the Nrf-2 pathway.
    Ji Y; Zhang X; Chen J; Song S; Fang S; Wang Z; Xu S; Xu Y; Liu J; Jiang C; Pan K; Zhang J; Wang L; Yin Z
    Phytomedicine; 2023 Jan; 109():154552. PubMed ID: 36610157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-140-5p ameliorates the high glucose-induced apoptosis and inflammation through suppressing TLR4/NF-κB signaling pathway in human renal tubular epithelial cells.
    Su J; Ren J; Chen H; Liu B
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32073611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (Pro)renin receptor mediates tubular epithelial cell pyroptosis in diabetic kidney disease via DPP4-JNK pathway.
    Xie S; Song S; Liu S; Li Q; Zou W; Ke J; Wang C
    J Transl Med; 2024 Jan; 22(1):26. PubMed ID: 38183100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acteoside alleviates UUO-induced inflammation and fibrosis by regulating the HMGN1/TLR4/TREM1 signaling pathway.
    Mao Y; Yu J; Da J; Yu F; Zha Y
    PeerJ; 2023; 11():e14765. PubMed ID: 36691481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway.
    Lu J; Li XQ; Chen PP; Zhang JX; Li L; Wang GH; Liu XQ; Jiang CM; Ma KL
    Acta Pharmacol Sin; 2024 Feb; 45(2):366-377. PubMed ID: 37770579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Mobility Group Box1 Inhibitor Glycyrrhizic Acid Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats.
    Zhang H; Zhang R; Chen J; Shi M; Li W; Zhang X
    Kidney Blood Press Res; 2017; 42(5):894-904. PubMed ID: 29241180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renoprotective effects of oleanolic acid and its possible mechanisms in rats with diabetic kidney disease.
    Liu Y; Hu Z; Xing H; Kang L; Chen X; Liu B; Niu K
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):1-9. PubMed ID: 36332469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ganoderma lucidum ameliorates the diabetic nephropathy via down-regulatory effect on TGFβ-1 and TLR-4/NFκB signalling pathways.
    Hassan HM; Mahran YF; Ghanim AMH
    J Pharm Pharmacol; 2021 Aug; 73(9):1250-1261. PubMed ID: 33847358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulinastatin Attenuates LPS-Induced Inflammation and Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis in Renal Tubular Epithelial Cells via Regulation of the TLR4/NF-κB and Nrf2/HO-1 Pathways.
    Chen F; Zhu J; Wang W
    Inflammation; 2021 Dec; 44(6):2323-2332. PubMed ID: 34585338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses.
    Yang D; Postnikov YV; Li Y; Tewary P; de la Rosa G; Wei F; Klinman D; Gioannini T; Weiss JP; Furusawa T; Bustin M; Oppenheim JJ
    J Exp Med; 2012 Jan; 209(1):157-71. PubMed ID: 22184635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PM
    Jiang Y; Peng Y; Yang X; Yu J; Yu F; Yuan J; Zha Y
    PeerJ; 2023; 11():e15856. PubMed ID: 37671359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
    Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from the root of Averrhoa carambola L., protects against diabetic kidney disease by inhibiting TLR4/TGFβ signaling pathway.
    Zhang H; Lu S; Chen L; Huang X; Jiang L; Li Y; Liao P; Wu X; Zhou X; Qin L; Wei J; Huang R
    Int Immunopharmacol; 2020 Mar; 80():106120. PubMed ID: 31972423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.